Cilostazol

Especificaciones

73963-72-1Número CAS

689-122-9Número CE

6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-oneNombre IUPAC

C20H27N5O2Fórmula química

369.5 g/molPeso molecular

cilostazol; 73963-72-1; Pletal; Cilostazole; Pletaal; OPC-13013; Cilostazolum; OPC-21; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; DTXSID9045132; 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; NSC-758936; CHEBI:31401; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; N7Z035406B; DTXCID7025132; 2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-; 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril; 2(1H)-quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-; 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy)-3,4-dihydro-1H-quinolin-2-one; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one; RefChem:58562; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyloxy)-3,4-dihydroquinolin-2(1H)-one; Cilostazolum [INN-Latin]; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one; 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; C20H27N5O2; MFCD00866780; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; MLS000028470; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one; NCGC00015207-07; SMR000058428; OPC 21; CAS-73963-72-1; Pletal (TN); SR-01000003107; BRN 3632107; UNII-N7Z035406B; Cilostazol [USAN:USP:INN:BAN:JAN]; Cilostazol (Standard); Tocris-1692; CILOSTAZOL [MI]; Opera_ID_488; CILOSTAZOL [INN]; CILOSTAZOL [JAN]; Spectrum2_001118; Spectrum3_001170; Spectrum4_000772; Spectrum5_001762; CILOSTAZOL [USAN]; Lopac-C-0737; CILOSTAZOL [VANDF]; CHEMBL799; C 0737; CILOSTAZOL [MART.]; CILOSTAZOL [USP-RS]; CILOSTAZOL [WHO-DD]; Lopac0_000218; REGID_for_CID_2754; SCHEMBL16128; BSPBio_002759; KBioGR_001184; MLS000758281; MLS000759507; MLS001076067; MLS002153891; SPECTRUM1505230; SPBio_001256; Cilostazol (JP18/USP/INN); GTPL7148; orb1224101; orb1310589; orb3141224; CILOSTAZOL [ORANGE BOOK]; SCHEMBL27771101; SCHEMBL29389547; HSDB 8312; KBio3_002259; CILOSTAZOL [USP MONOGRAPH]; HMS1922N15; HMS2093M14; HMS2096F16; HMS2234C06; HMS3260L17; HMS3268O09; HMS3412B18; HMS3654J13; HMS3676B18; HMS3713F16; HMS5079N07; Pharmakon1600-01505230; Tox21_110098; Tox21_500218; BDBM50225508; CCG-39646; EBC-11191; HY-17464R; MSK160188; NSC758936; s1294; AKOS015855512; Cilostazol, >=98% (HPLC), powder; OPC 13013; OPC 21; Pletaal; Tox21_110098_1; AC-4334; CS-1759; DB01166; FC03161; KS-5154; LP00218; NSC 758936; SDCCGSBI-0050206.P003; 2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-; NCGC00015207-01; NCGC00015207-02; NCGC00015207-03; NCGC00015207-04; NCGC00015207-05; NCGC00015207-06; NCGC00015207-08; NCGC00015207-09; NCGC00015207-10; NCGC00015207-11; NCGC00015207-12; NCGC00015207-14; NCGC00015207-25; NCGC00015207-26; NCGC00022153-02; NCGC00022153-04; NCGC00022153-05; NCGC00022153-06; NCGC00022153-07; NCGC00260903-01; HY-17464; SBI-0050206.P002; C2587; EU-0100218; NS00009762; SW199053-2; T0462; D01896; F20538; AB00382988-14; AB00382988_15; AB00382988_16; F862750; Q258591; SR-01000003107-2; SR-01000003107-4; SR-01000003107-7; BRD-K67017579-001-04-2; BRD-K67017579-001-05-9; BRD-K67017579-001-07-5; BRD-K67017579-001-13-3; BRD-K67017579-001-17-4; BRD-K67017579-001-26-5; BRD-K67017579-001-27-3; BRD-K67017579-001-28-1; SR-01000003107-10; Z1501485368; Cilostazol, United States Pharmacopeia (USP) Reference Standard; 6-[4-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril; 6-[4-(l-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxyl]-3,4-dihydrocarbostyril; Cilostazol, Pharmaceutical Secondary Standard; Certified Reference Material; 6-[4-(1-Cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone; Cilostazol MicronizedSinónimos